Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy

被引:253
作者
McMullen, Julie R. [1 ]
Amirahmadi, Fatemeh
Woodcock, Elizabeth A.
Schinke-Braun, Martina
Bouwman, Russell D.
Hewitt, Kimberly A.
Mollica, Janelle P.
Zhang, Li
Zhang, Yunyu
Shioi, Tetsuo
Buerger, Antje
Izumo, Seigo
Jay, Patrick Y.
Jennings, Garry L.
机构
[1] Baker Heart Res Inst, Expt Cardiol & Heart Failure Div, Melbourne, Vic 8008, Australia
[2] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA
[3] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
[4] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA
关键词
heart failure; signal transduction; heart growth; athlete's heart;
D O I
10.1073/pnas.0606663104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Physical activity protects against cardiovascular disease, and physiological cardiac hypertrophy associated with regular exercise is usually beneficial, in marked contrast to pathological hypertrophy associated with disease. The p110 alpha isoform of phosphoinositide 3-kinase (PI3K) plays a critical role in the induction of exercise-induced hypertrophy. Whether it or other genes activated in the athlete's heart might have an impact on cardiac function and survival in a setting of heart failure is unknown. To examine whether progressive exercise training and PI3K(p110 alpha) activity affect survival and/or cardiac function in two models of heart disease, we subjected a transgenic mouse model of dilated cardiomyopathy (DCM) to swim training, genetically crossed cardiac-specific transgenic mice with increased or decreased PI3K(p110 alpha) activity to the DCM model, and subjected PI3K(p110 alpha) transgenics to acute pressure overload (ascending aortic constriction). Life span, cardiac function, and molecular markers of pathological hypertrophy were examined. Exercise training and increased cardiac PI3K(p110 alpha) activity prolonged survival in the DCM model by 15-20%. In contrast, reduced PI3K(p110 alpha) activity drastically shortened lifespan by approximate to 50%. Increased PI3K(p110 alpha) activity had a favorable effect on cardiac function and fibrosis in the pressure-overload model and attenuated pathological growth. PI3K(p110 alpha) signaling negatively regulated G protein-coupled receptor stimulated extracellular responsive kinase and Akt (via PI3K, p110 gamma) activation in isolated cardiomyocytes. These findings suggest that exercise and enhanced PI3K(p110 alpha) activity delay or prevent progression of heart disease, and that supraphysiologic activity can be beneficial. Identification of genes important for hypertrophy in the athlete's heart could offer new strategies for treating heart failure.
引用
收藏
页码:612 / 617
页数:6
相关论文
共 37 条
  • [1] Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990 1994
    Barker, WH
    Mullooly, JP
    Getchell, W
    [J]. CIRCULATION, 2006, 113 (06) : 799 - 805
  • [2] Randomized, controlled trial of long-term moderate exercise training in chronic heart failure - Effects on functional capacity, quality of life, and clinical outcome
    Belardinelli, R
    Georgiou, D
    Cianci, G
    Purcaro, A
    [J]. CIRCULATION, 1999, 99 (09) : 1173 - 1182
  • [3] BRIAZGOUNOV I P, 1988, World Health Statistics Quarterly, V41, P242
  • [4] Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death
    Bueno, OF
    Molkentin, JD
    [J]. CIRCULATION RESEARCH, 2002, 91 (09) : 776 - 781
  • [5] Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase
    Buerger, A
    Rozhitskaya, O
    Sherwood, MC
    Dorfman, AL
    Bisping, E
    Abel, ED
    Pu, WT
    Izumo, S
    Jay, PY
    [J]. JOURNAL OF CARDIAC FAILURE, 2006, 12 (05) : 392 - 398
  • [6] Cohn JN, 1997, CIRCULATION, V95, P766
  • [7] Akt1 is required for physiological cardiac growth
    DeBosch, B
    Treskov, I
    Lupu, TS
    Weinheimer, C
    Kovacs, A
    Courtois, M
    Muslin, AJ
    [J]. CIRCULATION, 2006, 113 (17) : 2097 - 2104
  • [8] Fagard Robert H., 1997, Cardiology Clinics, V15, P397
  • [9] A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
    Fan, Qi-Wen
    Knight, Zachary A.
    Goldenberg, David D.
    Yu, Wei
    Mostov, Keith E.
    Stokoe, David
    Shokat, Kevan M.
    Weiss, William A.
    [J]. CANCER CELL, 2006, 9 (05) : 341 - 349
  • [10] Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation
    Foukas, LC
    Claret, M
    Pearce, W
    Okkenhaug, K
    Meek, S
    Peskett, E
    Sancho, S
    Smith, AJH
    Withers, DJ
    Vanhaesebroeck, B
    [J]. NATURE, 2006, 441 (7091) : 366 - 370